Properties
Description
LY2835219, soluble in DMSO and ethanol and insoluble in water, is an CDK kinase inhibitor that disrupts cell division processes. It targets CDK1/cyclinB1, CDK2/cyclinE, Cdk4/cyclin D1, and Cdk5/p25.
Molecular Formula
C27H32F2N8
Targets
CDK1/cyclinB1: 1627 nM; CDK2/cyclinE: 504 nM; Cdk4/cyclin D1: 2 nM; Cdk5/p25: 355 nM
Solubility
DMSO: 6 mg/mL (11.84 mM); Water: Insoluble; Ethanol: 8 mg/mL (15.79 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
LY2835219 (Abemaciclib) can be used to study the targeted inhibition of CDK4/6 in cancer therapies.